Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
74.2M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
498K
-
Shares change
-
-16.8M
-
Total reported value, excl. options
-
$202K
-
Value change
-
-$7.88M
-
Number of buys
-
2
-
Number of sells
-
-25
-
Price
-
$0.41
Significant Holders of ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) as of Q2 2016
31 filings reported holding ENZN - ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share as of Q2 2016.
ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 498K shares
of 74.2M outstanding shares and own 0.67% of the company stock.
Largest 10 shareholders include CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (254K shares), ACADIAN ASSET MANAGEMENT LLC (122K shares), Ancora Advisors, LLC (50K shares), TUDOR INVESTMENT CORP ET AL (48K shares), O'SHAUGHNESSY ASSET MANAGEMENT, LLC (11.2K shares), MONARCH CAPITAL MANAGEMENT INC/ (10K shares), CT Financial Advisors LLC (2K shares), GOLDMAN SACHS GROUP INC (0 shares), CSS LLC/IL (0 shares), and Concert Wealth Management Inc. (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.